In China, doctors are treating more and more cancer patients with the gene-editing tool known as CRISPR. But research on the technique is still limited.
David Greene In Tempe
David Greene, of NPR's Morning Edition, visited Tempe in February. His captivating talk included personal and professional tales from his career at NPR, followed by an audience Q & A.